D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 82 Citations 27,455 407 World Ranking 10829 National Ranking 1020

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Statistics

His primary areas of investigation include Internal medicine, Breast cancer, Demography, Surgery and Epidemiology. His studies in Internal medicine integrate themes in fields like Endocrinology, Gynecology, Oncology and Vaccination. Chris Robertson has included themes like Cyclophosphamide and Chemotherapy in his Breast cancer study.

In his study, Cross-sectional study, Environmental health, Biotechnology, Vitamin and Micronutrient is inextricably linked to Odds ratio, which falls within the broad field of Demography. His biological study spans a wide range of topics, including Sentinel lymph node, Urology, Metastasis and Axilla. He interconnects Lower urinary tract symptoms, International Prostate Symptom Score, Cohort study and Public health in the investigation of issues within Epidemiology.

His most cited work include:

  • A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. (1698 citations)
  • Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). (919 citations)
  • Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women (720 citations)

What are the main themes of his work throughout his whole career to date?

Chris Robertson mainly focuses on Internal medicine, Breast cancer, Demography, Oncology and Epidemiology. His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology and Surgery. His work investigates the relationship between Breast cancer and topics such as Gynecology that intersect with problems in Obstetrics.

His Demography study integrates concerns from other disciplines, such as Incidence, Cohort study, Cohort and Confidence interval. The Cohort study combines topics in areas such as Immunology and Vaccination. He combines subjects such as Odds ratio and Public health with his study of Epidemiology.

He most often published in these fields:

  • Internal medicine (35.14%)
  • Breast cancer (13.29%)
  • Demography (17.12%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (35.14%)
  • Vaccination (15.09%)
  • Epidemiology (14.19%)

In recent papers he was focusing on the following fields of study:

Chris Robertson spends much of his time researching Internal medicine, Vaccination, Epidemiology, Health care and Public health. His Medical prescription research extends to the thematically linked field of Internal medicine. His Vaccination research includes themes of Pediatrics and Confidence interval.

His Epidemiology research integrates issues from Demography and Cohort study. While the research belongs to areas of Demography, Chris Robertson spends his time largely on the problem of Odds ratio, intersecting his research to questions surrounding Disease and Psychological intervention. His work deals with themes such as Modifiable areal unit problem, Infection control, Pandemic, Algorithm and Population level, which intersect with Public health.

Between 2015 and 2021, his most popular works were:

  • Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study (120 citations)
  • Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study (120 citations)
  • Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results. (116 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Statistics

His primary scientific interests are in Vaccination, Internal medicine, Cervical screening, Retrospective cohort study and Immunology. Chris Robertson focuses mostly in the field of Cervical screening, narrowing it down to matters related to Cohort and, in some cases, Cross-sectional study and Logistic regression. His work in Retrospective cohort study addresses issues such as Cervical intraepithelial neoplasia, which are connected to fields such as Population study, Obstetrics and Gynecology.

His study in Immunology is interdisciplinary in nature, drawing from both Demography and Case-control study. His research in Randomized controlled trial tackles topics such as Cancer which are related to areas like Surgery. His Cohort study study incorporates themes from Odds ratio and Epidemiology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.

Umberto Veronesi;Giovanni Paganelli;Giuseppe Viale;Alberto Luini.
The New England Journal of Medicine (2003)

2628 Citations

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

Raymond Rosen;Jens Altwein;Peter Boyle;Roger S Kirby.
European Urology (2003)

1461 Citations

Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.

U Veronesi;G Paganelli;G Viale;V Galimberti.
Journal of the National Cancer Institute (1999)

1004 Citations

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women

U Veronesi;P Maisonneuve;A Costa;V Sacchini.
The Lancet (1998)

1003 Citations

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.

James Lopez Bernal;James Lopez Bernal;James Lopez Bernal;Nicholas Andrews;Nicholas Andrews;Charlotte Gower;Chris Robertson.
BMJ (2021)

665 Citations

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.

Aziz Sheikh;Jim McMenamin;Bob Taylor;Chris Robertson.
The Lancet (2021)

662 Citations

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels

M. Colleoni;A. Rocca;M. T. Sandri;L. Zorzino.
Annals of Oncology (2002)

550 Citations

Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients.

S. Gandini;H. Merzenich;C. Robertson;P. Boyle.
European Journal of Cancer (2000)

516 Citations

Very young women (<35 years) with operable breast cancer: features of disease at presentation

M. Colleoni;N. Rotmensz;C. Robertson;L. Orlando.
Annals of Oncology (2002)

503 Citations

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria.

Georg Bartsch;Wolfgang Horninger;Helmut Klocker;Andreas Reissigl.
Urology (2001)

422 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Chris Robertson

Giuseppe Viale

Giuseppe Viale

University of Milan

Publications: 127

Paolo Veronesi

Paolo Veronesi

European Institute of Oncology

Publications: 118

Giovanni Paganelli

Giovanni Paganelli

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Publications: 88

Umberto Veronesi

Umberto Veronesi

European Institute of Oncology

Publications: 77

Viviana Galimberti

Viviana Galimberti

European Institute of Oncology

Publications: 67

Marco Colleoni

Marco Colleoni

European Institute of Oncology

Publications: 64

Nicole Rotmensz

Nicole Rotmensz

European Institute of Oncology

Publications: 55

Patrick Maisonneuve

Patrick Maisonneuve

European Institute of Oncology

Publications: 48

Claus G. Roehrborn

Claus G. Roehrborn

The University of Texas Southwestern Medical Center

Publications: 46

Richard Pebody

Richard Pebody

Public Health England

Publications: 45

Giancarlo Pruneri

Giancarlo Pruneri

University of Milan

Publications: 44

Robert S. Kerbel

Robert S. Kerbel

University of Toronto

Publications: 39

Peter Boyle

Peter Boyle

University of Edinburgh

Publications: 39

Aron Goldhirsch

Aron Goldhirsch

European Institute of Oncology

Publications: 37

Vincenzo Bagnardi

Vincenzo Bagnardi

University of Milan

Publications: 36

Roberto Orecchia

Roberto Orecchia

European Institute of Oncology

Publications: 35

Trending Scientists

Agostino Dovier

Agostino Dovier

University of Udine

Rittwik Jana

Rittwik Jana

AT&T (United States)

Jiafu Tang

Jiafu Tang

Dongbei University of Finance and Economics

Tao Li

Tao Li

Dongguan University of Technology

Masahiro Goto

Masahiro Goto

Kyushu University

Ken Hosoya

Ken Hosoya

Kyoto Prefectural University

Aleksandr Noy

Aleksandr Noy

Lawrence Livermore National Laboratory

David H. Wyllie

David H. Wyllie

Public Health England

David E. Golan

David E. Golan

Harvard Medical School

Peilin Jia

Peilin Jia

The University of Texas Health Science Center at Houston

Jesus G. Valenzuela

Jesus G. Valenzuela

National Institutes of Health

Pavel Kabat

Pavel Kabat

World Meteorological Organization

Evangelia Samoli

Evangelia Samoli

National and Kapodistrian University of Athens

Peter A. Wyman

Peter A. Wyman

University of Rochester

Garrett Prestage

Garrett Prestage

University of New South Wales

Mary T. Bassett

Mary T. Bassett

Harvard University

Something went wrong. Please try again later.